KIMBERLY KOVAL: Open Payments
NPI 1083987101 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,229 in 121 payments from 44 companies in 2025. Trend: 2023 $2,970 · 2024 $5,206 · 2025 $3,229
Food & beverage: $1,952Long term medical supply or device loan: $1,000Education: $277
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $1,192 |
| AstraZeneca Pharmaceuticals LP | 11 | $212 |
| ABBVIE INC. | 10 | $164 |
| Incyte Corporation | 4 | $157 |
| Janssen Biotech, Inc. | 4 | $136 |
| SEAGEN INC. | 1 | $100 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| PFIZER INC. | 6 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
Products named: KISQALI, ERLEADA, ELAHERE, OPDIVO, Fabhalta, ZYNLONTA, ENHERTU, BRUKINSA.
Industry payments across NJ — which companies pay providers there.
